Bathiya Ratnayake

Dr. Bathiya Ratnayake

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 December 2018 in Pancreatology
Verified
Journal Article
Closed access
BRBathiya Ratnayake
Bathiya Ratnayake
BLBenjamin Pt. Loveday
Benjamin Pt. Loveday
SSShailesh V. Shrikhande
Shailesh V. Shrikhande
JWJohn Albert Windsor
John Albert Windsor
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana

13 January 2022 in Surgery
Verified
Journal Article
Closed access
BRBathiya Ratnayake
Bathiya Ratnayake
SPSayali A. Pendharkar
Sayali A. Pendharkar
SCSaxon Connor
Saxon Connor
JKJonathan Koea
Jonathan Koea
DSDiana Sarfati
Diana Sarfati
JWJohn Albert Windsor
John Albert Windsor

10 April 2018 in Journal of Anatomy
Verified
Journal Article
Closed access
PDF file
BRBathiya Ratnayake
Bathiya Ratnayake
AEAlistair Brian James Escott
Alistair Brian James Escott
APAnthony Ronald John Phillips
Anthony Ronald John Phillips
JWJohn Albert Windsor
John Albert Windsor

8 August 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
CWCameron I. Wells
Cameron I. Wells
BRBathiya Ratnayake
Bathiya Ratnayake
JPJenni Perrin
Jenni Perrin
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana

8 August 2023 in Annals of Surgery
Verified
Journal Article
Open access
LLLauri I. Lavikainen
Lauri I. Lavikainen
Gordon H. GuyattGordon H. Guyatt
Gordon H. Guyatt
VSVille Sallinen
Ville Sallinen
PKPaul Jack Karanicolas
Paul Jack Karanicolas
RCRachel J. Couban
Rachel J. Couban
RTRiikka M. Tähtinen
Riikka M. Tähtinen
Objective: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery. Background: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and bleeding risks that vary between procedures; their magnitude remains uncertain. Methods: We identified observational studies reporting procedure-specific risks of symptomatic VTE or major bleeding after abdominal surgery, adjusted the reported estimates for thromboprophylaxis and length of follow-up, and estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated evidence certainty. Results: After eligibility screening, 285 studies (8,048,635 patients) reporting on 40 general abdominal, 36 colorectal, 15 upper gastrointestinal, and 24 hepatopancreatobiliary surgery procedures proved eligible. Evidence certainty proved generally moderate or low for VTE and low or very low for bleeding requiring reintervention. The risk of VTE varied substantially among procedures: in general abdominal surgery from a median of <0.1% in laparoscopic cholecystectomy to a median of 3.7% in open small bowel resection, in colorectal from 0.3% in minimally invasive sigmoid colectomy to 10.0% in emergency open total proctocolectomy, and in upper gastrointestinal/hepatopancreatobiliary from 0.2% in laparoscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer. Conclusions: VTE thromboprophylaxis provides net benefit through VTE reduction with a small increase in bleeding in some procedures (eg, open colectomy and open pancreaticoduodenectomy), whereas the opposite is true in others (eg, laparoscopic cholecystectomy and elective groin hernia repairs). In many procedures, thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.